Article Listing - Amgen

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

Highlighting its ongoing R&D in its recently released annual report for 1991, Denmark's Novo Nordisk notes that it intends to...

CIBA-GEIGY CONFIDENT IN FORTHCOMING RESULTS

27 April 1992

Ciba-Geigy chairman Alex Krauer has expressed confidence in the company's forthcoming 1992 results. He adds that the company is actively...

PROMOTIONS AT MERCK & CO

27 April 1992

At world drug leader Merck & Co, Louis Sherwood has been named senior vice president of medical and scientific affairs....

APPOINTMENTS AT US NAAIDC

27 April 1992

US Health and Human Services Secretary Louis Sullivan has announced five appointments to the National Advisory Allergy and Infectious Diseases...

FRENCH VOLUNTARY AIDS TESTING MEASURES

27 April 1992

The French government has adopted four measures to encourage voluntary AIDS testing and will boost the state AIDS prevention budget...

EPHMRA MEETING

27 April 1992

The 31st European Pharmaceutical Market Research Association members conference will take place in Lyon, France, from June 3 to June...

CENTOXIN APPROVAL DELAYED AGAIN

27 April 1992

In a further blow to Centocor's prospects, the US Food and Drug Administration has again decided not to approve the...

METHOTREXATE IN JUVENILE ARTHRITIS

27 April 1992

Methotrexate is known to be effective in adults with severe rheumatoid arthritis, but there has been a lack of data...

SB WINS QUEEN'S AWARD FOR BACTROBAN

27 April 1992

In the UK, SmithKline Beecham has won a 1992 Queen's award for technology for its topical antibiotic Bactroban (mupirocin), which...

ISIS ACQUIRES PNA OLIGOMER RIGHTS

27 April 1992

The antisense oligonucleotide specialist Isis Pharmaceuticals has signed a research and development agreement with investigators at the Panum Institute of...

Showing 94161-94170 of 95353 articles